4-Hydroperoxy cyclophosphamide Catalog No.:M12466-10 Single-dose administration of BMS-201038 is

Single-dose administration of BMS-201038 is shown to reduce serum triglycerides by 35% and 47% at 0

Mikusova K

and are often over-expressed in human cancers

CCCCC1OC2=CC=CC=C2C=1C(=O)C1=CC(I)=C(OCCN(CC)CC)C(I)=C1

Sandramycin

4-Hydroperoxy cyclophosphamide Catalog No.:M12466-10 Single-dose administration of BMS-201038 is4 Hydroperoxy cyclophosphamide is the active metabolite form of the prodrug Cyclophosphamide. 4 Hydroperoxy cyclophosphamide crosslinks DNA and induces T cell apoptosis independent of death receptor activation, but activates mitochondrial death pathways through production of reactive oxygen species (ROS). 4 Hydroperoxy cyclophosphamide has the potential for lymphomas and autoimmune disorders. Product information CAS Number: 39800 16 3 Molecular